Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic and predictive role of epidermal growth factor receptor mutation in recurrent pulmonary adenocarcinoma after curative resection

Published:2014-04-22 Issue:3 Volume:47 Page:556-562
ISSN:1873-734X
Container-title:European Journal of Cardio-Thoracic Surgery
language:en
Short-container-title:

Author:

Jeon Jae Hyun,Kang Chang Hyun,Kim Hye-seon,Seong Yong Won,Park In Kyu,Kim Young Tae

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,General Medicine,Surgery

Link

http://academic.oup.com/ejcts/article-pdf/47/3/556/17782732/ezu177.pdf

Reference25 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Disease recurrence after resection for stage I lung cancer;al-Kattan;Eur J Cardiothorac Surg,1997

3. Long-term results of combined-modality therapy in resectable non-small-cell lung cancer;Martin;J Clin Oncol,2002

4. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group;Pignon;J Clin Oncol,2008

5. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib;Lynch;N Engl J Med,2004

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma;BMC Cancer;2023-03-14

2. Outcomes of immune checkpoint inhibitors for postoperative recurrence of non-small cell lung cancer;General Thoracic and Cardiovascular Surgery;2023-02-22

3. Molecular Markers in Guiding Lung Cancer Diagnosis and Treatment;Journal of Men's Health;2022-07-28

4. EGFR mutation is not a prognostic factor for CNS metastasis in curatively resected lung adenocarcinoma patients;Lung Cancer;2022-05

5. Epidermal growth factor receptor (EGFR)—tyrosine kinase inhibitors as a first-line treatment for postoperative recurrent and EGFR-mutated non-small-cell lung cancer;Interactive CardioVascular and Thoracic Surgery;2021-10-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3